Nvidia (NASDAQ:NVDA) has entered into a partnership with Abridge to develop a specialised artificial intelligence model tailored for healthcare use cases, according to a report by the Wall Street Journal. Abridge is known for its AI-powered note-taking platform used by medical professionals.
The collaboration reflects growing investment across the technology sector in healthcare-focused AI solutions designed to improve clinical workflows and patient care.
Model to Focus on Clinical Conversations
The companies said the new AI model will be designed specifically around clinical interactions and conversations between healthcare providers and patients.
Rather than being broadly distributed, the model will be deployed exclusively within Abridge’s platform, where it is expected to support a range of healthcare-related tasks including clinical documentation and decision support.
Nvidia is already an investor in Abridge, further strengthening the strategic relationship between the two companies.
Built Using Nvidia’s Nemotron Models
According to Kimberly Powell, Nvidia’s vice president of healthcare, the new healthcare-focused model will be developed using the company’s Nemotron family of open AI models.
Open models are generally made available for users to download, customise and adapt without charge. However, they differ from fully open-source systems because they do not necessarily provide unrestricted access to training datasets and underlying source code.
The approach is intended to accelerate the creation of AI systems that can better understand specialised healthcare terminology and clinical workflows.
Earlier Integration of Clinical Intelligence
Powell highlighted the benefits of incorporating healthcare-specific expertise during the early stages of model development rather than adapting general-purpose models later.
“There’s an opportunity now to take these models and adapt them with this clinical intelligence at a much earlier stage of model development,” Powell said.
The companies believe this approach could improve the performance and relevance of AI tools used by clinicians, particularly in areas involving patient documentation and medical decision-making.
Healthcare Emerges as Key AI Growth Area
The partnership comes as technology companies and artificial intelligence developers increasingly target the healthcare sector as a major growth opportunity.
AI tools are being deployed across a wide range of medical applications, from administrative support and clinical documentation to diagnostics, treatment planning and patient engagement.
By combining Nvidia’s AI development capabilities with Abridge’s healthcare expertise, the companies aim to create more specialised AI systems capable of supporting healthcare professionals in everyday clinical practice.